rs797044569
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_002055.5(GFAP):c.197G>C(p.Arg66Pro) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
GFAP
NM_002055.5 missense
NM_002055.5 missense
Scores
11
7
1
Clinical Significance
Conservation
PhyloP100: 4.14
Genes affected
GFAP (HGNC:4235): (glial fibrillary acidic protein) This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.971
PP5
Variant 17-44915290-C-G is Pathogenic according to our data. Variant chr17-44915290-C-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 372607.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFAP | NM_002055.5 | c.197G>C | p.Arg66Pro | missense_variant | 1/9 | ENST00000588735.3 | NP_002046.1 | |
GFAP | NM_001363846.2 | c.197G>C | p.Arg66Pro | missense_variant | 1/10 | NP_001350775.1 | ||
GFAP | NM_001242376.3 | c.197G>C | p.Arg66Pro | missense_variant | 1/7 | NP_001229305.1 | ||
GFAP | NM_001131019.3 | c.197G>C | p.Arg66Pro | missense_variant | 1/8 | NP_001124491.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GFAP | ENST00000588735.3 | c.197G>C | p.Arg66Pro | missense_variant | 1/9 | 1 | NM_002055.5 | ENSP00000466598 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 20, 2015 | The R66P variant has not been published as a pathogenic variant, nor has it been reported as a benign polymorphism to our knowledge. It was notobserved in approximately 6,500 individuals of European and African American ancestry in the NHLBIExome Sequencing Project, indicating it is not a common benign variant in these populations. The R66Pvariant is a non-conservative amino acid substitution, which is likely to impact secondary protein structureas these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a highlyconserved position that is predicted to be within the highly conserved Head region of the GFAP protein. Insilico analysis predicts this variant is probably damaging to the protein structure/function. A missensevariant at the same position (R66Q), as well as missense variants in nearby residues have beenreported in the Human Gene Mutation Database in association with Alexander disease (Stenson et al.,2014), supporting the functional importance of this region of the protein. This is a strong candidatefor a pathogenic variant, however the possibility that it is a benign variant cannot be excluded. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Pathogenic
.;D;.;.;.;D;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
.;M;.;M;M;.;.;.;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;.;D;D;.;.;.;.;.
REVEL
Pathogenic
Sift
Pathogenic
.;.;D;D;.;.;.;.;.
Sift4G
Uncertain
.;.;D;D;.;D;D;.;.
Polyphen
0.70
.;P;.;.;.;.;.;.;.
Vest4
0.95, 0.95, 0.94
MutPred
Loss of MoRF binding (P = 0.0547);Loss of MoRF binding (P = 0.0547);Loss of MoRF binding (P = 0.0547);Loss of MoRF binding (P = 0.0547);Loss of MoRF binding (P = 0.0547);Loss of MoRF binding (P = 0.0547);Loss of MoRF binding (P = 0.0547);Loss of MoRF binding (P = 0.0547);Loss of MoRF binding (P = 0.0547);
MVP
1.0
MPC
0.66
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at